NCT03579056 (GRIMM) is a clinical trial in Geriatric Disorders, sponsored by University Hospital, Angers.

Who is sponsoring NCT03579056?

NCT03579056 is sponsored by University Hospital, Angers.

What condition does NCT03579056 study?

NCT03579056 studies Geriatric Disorders.

Is NCT03579056 still recruiting?

NCT03579056 is currently completed. Last updated 6 July 2018.

Last reviewed 2018-07-06 · How we verify

NCT03579056: GRIMM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

GeRIatric Multidisciplinary Meeting

Completed Last updated 6 July 2018

What this trial tests

trial in Geriatric Disorders in 734 participants. Completed in 4 September 2017.

Timeline

16 February 2017

Primary endpoint
4 September 2017

4 September 2017

Quick facts

Lead sponsor	University Hospital, Angers
Status	Completed
Study type	OBSERVATIONAL
Enrollment	734
Start date	16 February 2017
Primary completion	4 September 2017
Estimated completion	4 September 2017
Sites	1 location across France

Conditions studied

Geriatric Disorders — all drugs for Geriatric Disorders →

Sponsor

University Hospital, Angers

Who can join

64 and older, any sex, with Geriatric Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to develop a typology of patients referred to the Geriatric Multidisciplinary Meeting (GMM) according to their demographic and clinical profile. The secondary objectives are: * To distinguish the different types of answers given by the GMM according to the demands and situations. * To study the factors associated with the orientation proposed by the GMM * To examine the adequacy between the orientation proposed by the GMM and the pathway actually taken * To compare the diagnoses made during the following year with the data collected during the GMM

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Angers trials

Trials by the same sponsor.

NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
NCT07470294 — Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric Popula · not yet recruiting
NCT07409597 — Autobiographical Memory, Future Thought, and Eye Movements in Huntington's Disease · NA · not yet recruiting
NCT07468565 — Surgical Approach for the Treatment of Hirschsprung Disease Using the Swenson Technique (SMILES) · not yet recruiting
NCT07452952 — Relationship Between the Level of Positive End-expiratory Pressure and Venous Congestion During Acute Respiratory Distre · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03579056 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Angers
Last refreshed: 6 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03579056.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing